Urodelia Overview

  • Founded
  • 2003
  • Status
  • Private
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $1M
Latest Deal Amount
  • Investors
  • 1

Urodelia General Information


Developer of alternative medicine designed to treat and cure cancer. The company's anticancer treatments focus on strengthening of immune defences of patients by using nanoparticle and biotechnology methods, enabling doctors to reduce the pain of patients suffering from cancer and attempt to cure cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • RCS Toulouse
  • Route De Saint Thomas Lieudit Le Gaillard
  • 31470 Saiguède
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Urodelia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Product Crowdfunding 01-Jun-2010 $1M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Urodelia’s complete valuation and funding history, request access »

Urodelia Executive Team (2)

Name Title Board Seat Contact Info
Patrick Frayssinet Co-Founder & Deputy Chief Executive Officer
Nicole Rouquet Co-Founder & Managing Director
To view Urodelia’s complete executive team members history, request access »

Urodelia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nubbo Accelerator/Incubator 000 0000 000000 0
To view Urodelia’s complete investors history, request access »